Viewing Study NCT06523556


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-06 @ 12:52 PM
Study NCT ID: NCT06523556
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2024-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Sponsor: Uma Borate
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module